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Background: C-reactive protein (CRP) is widely used to detect bacterial infection in children. We investigated the
impact of CRP test results on decision-making and summarized the evidence base (EB) of CRP testing.
Methods: We collected information from the hospital records of 91 neonates with suspected sepsis and of 152
febrile children with suspected infection on the number of ordered CRP tests, the number of EB-CRP tests, and the
impact of the test results on decision-making. CRP diagnostic accuracy studies focusing on pediatric infections were
reviewed critically. The main outcomes were the proportion of CRP tests that were EB and the proportion of tests
that affected decision-making. A secondary outcome was the overall one-year expenditure on CRP testing.
Results: The current EB for CRP testing in pediatric infections is weak and suggests that CRP is of low diagnostic
value. Approximately 54.8% of tests performed for suspected neonatal sepsis and 28% of tests performed for other
infections were EB; however, the results of only 12.9% of neonatal sepsis tests and of 29.9% of tests on children with
other infections informed decision-making. The one-year overall cost for CRP testing and related health care was
$26,715.9.
Conclusions: The routine ordering of CRP for children with infections is based on weak evidence. The impact of
the CRP test results on decision-making is rather small, and CRP ordering may contribute to unnecessary health care
expenditures. Better quality research is needed to definitively determine the diagnostic accuracy of CRP levels in
children with infections.
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C-reactive protein (CRP) is an acute-phase reactant
that is synthesized by the liver within six hours after
the onset of inflammation and tissue necrosis [1]. Its
rapid synthesis, short half-life and rapid decline with
recovery, together with an association between greater
increases and serious bacterial infections, have made
the CRP test popular. This test is often requested to
help discriminate viral infections from bacterial infec-
tions or monitor the response to antibiotics [2]. The
CRP level is widely used to detect bacterial infections
in children with fever and in neonates with suspected* Correspondence: mn04@aub.edu.lb
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reproduction in any medium, provided the orsepsis [2]. However, recent evidence on the utility of
the CRP test in patients with various infections sug-
gests that there are great variations in the sensitivity,
specificity, and predictive values of this test, which may
compromise its diagnostic accuracy [3-5]. In addition,
we have observed that despite its wide use as a diag-
nostic tool for several acute pediatric infections, CRP
testing rarely impacted clinical decision-making. In our
setting, CRP is ordered routinely on children presenting
with symptoms and/or signs suggestive of acute infec-
tion as a baseline test to help discriminate viral from
bacterial infection. Similarly, CRP is ordered routinely
on all neonates with suspected neonatal sepsis in the
neonatal intensive care unit. We therefore conducted
this study to determine how often the results of CRP
testing impact clinical decision-making regardingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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determine how often the ordering of the CRP test is
evidence based.
Methods
We conducted a retrospective chart review that included
all pediatric patients admitted to the pediatric ward or
the neonatal intensive care unit (NICU) of the American
University of Beirut Medical Center (AUBMC) between
January 1 and December 31, 2008, as identified by the
Hospital Medical Records Department. AUBMC is a
420-bed university hospital that offers tertiary health care
and is accredited by the Joint Commission International
(JCIA). A case was reviewed in detail if it met all of the
following inclusion criteria: age between 0 and 18 years;
acute infection or neonatal sepsis as the admission diag-
nosis; and serum CRP testing performed at baseline
upon admission to the emergency department (ED) or
NICU. We excluded children with malignancies, con-
genital or acquired immune disorders, septic shock, con-
genital heart disease, severe chronic disease involving
any organ system, rheumatic disease, collagen vascular
disease, and acute or chronic hepatic disorders.
The data collected from the hospital records included
age, admission diagnosis, final diagnosis, number of CRP
tests performed, length of hospital stay, impact of CRP
results on clinical decision-making or management (Yes/
No) based on our review of physicians’ notes, additional
laboratory tests or treatment preformed based on the
CRP results, and the overall amount of the hospital bill
at discharge. The impact of the CRP results on decision-
making with respect to treatment or further laboratory
testing was coded as “Yes” if clearly reflected in physi-
cians’ notes. Otherwise, it was coded as “No”. This study
was approved by the Institutional Review Board.
To assess the evidence base for CRP testing for each
type of infection, we performed a systematic search for the
published research available to physicians at the time at
which the selected patients were admitted to the hospital
(until end of 2008). We used the keywords C-reactive pro-
tein AND (infection OR neonatal sepsis) to search
PubMed Clinical Queries for diagnostic studies (broad
search) and to search the Cochrane Library for systematic
reviews of diagnostic accuracy. The search was performed
by one of the authors (MN) and was last updated on De-
cember 16, 2011, for studies published after 2008. Studies
were reviewed in detail if the participants were children
(ages 0-18 years) with acute infections in whom CRP test-
ing was blindly and independently compared with ad-
equate microbiologic or radiologic reference standards,
and the diagnostic accuracy of CRP test results was evalu-
ated as an outcome. Studies of neonatal sepsis were
reviewed independently by two authors (MN and AH),
whereas studies on other acute pediatric infections werereviewed independently by MN and MK. The quality as-
sessment of each study was performed using the QUA-
DAS tool [6]. Decisions on quality and study inclusion
were performed independently by the same authors for
the two categories of studies (MN and AH for neonatal
sepsis; MN and MK for other acute pediatric infections),
and these decisions were subsequently compared and dis-
cussed further among the authors.
For each type of infection, CRP testing was judged to
be evidence-based if at least one valid study reported it
to be of significant diagnostic value, based on likelihood
ratios, sensitivity, specificity, and predictive values, for
the discrimination of viral infections from bacterial
infections. Studies published before the end of 2008, the
year during which admissions that are under review took
place, are summarized in tables (Additional file 1 and
Additional file 2). Table 1 summarizes our decision rules
for the evidence base for CRP testing for each type of in-
fection. The determination of CRP ordering as evidence-
based in each case was made according to the patient’s
working diagnosis at the time CRP was measured, and
not based on the patient’s final diagnosis.
Statistical analysis
We summarized the variables of interest using the means
and standard deviations, medians, ranges, and propor-
tions. The main outcome measures were the proportion
of ordered CRP tests that were supported by evidence
and the proportion of tests that resulted in a change in
management, such as the requesting of further tests or
the stopping or starting of antibiotics. A secondary out-
come was the overall one-year expenditure on CRP tests.
We used the Statistical Package for Social Science (SPSS
version 18, Chicago, IL) for data analysis.
Results
Overall, we screened 2250 hospital records (nursery =
1485; pediatric ward = 765). Of these, 243/2250 (10.8%)
hospital admissions met our inclusion criteria: 91/243
(37.4%) from the NICU and 152/243 (62.6%) from the
pediatric ward. These cases constituted 6.1% (91/1485)
of nursery admissions and 19.9% (152/765) of overall
ward admissions, respectively. A total of 517 CRP tests
were performed during one year: 254/517 (49.1%) for the
ward patients and 263/517 (50.9%) for the NICU
patients. The baseline characteristics of the NICU and
ward patients and their values of the CRP-related vari-
ables are detailed in Tables 2 and 3, respectively.
For the 91 NICU admissions, 263 CRP tests were per-
formed during the initial work up of suspected neonatal
sepsis episodes. Of these, 144/263 (54.8%) were serial
CRP tests and hence were considered evidence based
(EB), whereas the remaining 119/263 (45.2%) tests were
single tests and were considered non-evidence based
Table 1 Decision rules on the evidence-base for CRP testing in acute pediatric infections and neonatal sepsis
Infection Type Evidence-Based CRP testing Non-Evidence-Based CRP testing Highest available
Level of Evidence
Fever without focus ___ Baseline &/or follow up testing in patients with
fever without focus who are >28 days of age
Level I (SR)
Pneumonia ___ Baseline &/or follow up testing in febrile
children with respiratory symptoms and an
admission diagnosis of bronchitis, bronchiolitis,
asthma, or pneumonia
Level I (SR)
Urinary tract infections (UTI) Baseline &/or follow up
testing in febrile pyelonephritis
Baseline testing in febrile infants
suspected to have UTI
Level III & IV (Cross-sectional &
retrospective studies)
Acute gastroenteritis ___ Baseline &/or follow up testing in febrile or
non-febrile acute gastroenteritis
No evidence
Meningitis ___ 1. Baseline testing in febrile children
suspected to have meningitis
Level IV (Retrospective studies)




Baseline &/or follow up




Acute appendicitis Baseline &/or follow up
testing in acute appendicitis
___ Level IV
(Cross-sectional studies)
Acute otitis media ___ Baseline &/or follow up
testing in acute otitis media
Level II
(Cross-sectional studies)
Cellulitis ___ Any baseline or follow up
testing in patients with




Neonatal sepsis Testing on three
consecutive days of a suspected
sepsis episode
A single determination of CRP Level I
(SR)
Table 2 Baseline characteristics of NICU and ward patients
NICU Ward
Number of cases 91 152
Male Gender N (%) 38 (41.8%) 75 (49.3%)
Gestational Age
(weeks)
Mean (SD) = 34.6 (4.1) ___
Median = 35
Range= 25-42





Sepsis = 91 (100%) Bacterial = 123 (80.9%)
Non-bacterial = 29 (19.1%)
Final Diagnosis N (%) Sepsis = 44 (48.4%) Bacterial = 69 (45.4%)
Prematurity = 21 (23.1%) Non-bacterial = 83 (54.6%)
Viral = 7 (7.7%)
Other = 19 (20.9%)
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Table 3 NICU and ward patients’ CRP-related outcomes and costs
CRP-related variables NICU Ward
Baseline CRP (mg/L) Mean (SD) = 5.5 (10.1) Mean (SD) = 65.9 (85.8)
Median = 1.6 Median= 31.2
Range= 0.1 – 68.4 Range= 0.4-512.2
Total No. of CRP tests requested/case Mean (SD) = 2.9 (2.7) Mean= 1.7 (1.0)
Median = 2 Median = 1.0
Range= 1-12 Range= 1 - 6
Overall No. of EB-CRP tests (%) 144/263 (54.8%) 71/254 (28%)
Overall No. of clinical decisions
affected by CRP (%)
34/263 (12.9%) 76/254 (29.9%)
CRP overall cost/year ($) 12,799.3 12,517
CRP overall cost/case ($) Mean (SD) = 140.7 (131.7) Mean (SD) = 82.3 (48.4)
Median = 97.3 Median= 49.3
Range= 48.7 – 584.0 Range= 48.7 – 292.0
% Hospital bill due to CRP 1.1% 3.34%
Non-EB CRP overall cost/year ($) 5986.0 8868.7
Non-EB CRP overall cost/case ($) Mean (SD) = 65.8 (64.6) Mean (SD) = 58.3 (46.6)
Median = 48.7 Median= 48.7
Range= 0.0 – 292.0 Range= 0.0 – 292.0
% CRP cost due to non-EB tests/year 46.8% 70.8%
Cost of additional health care due to
non-EB CRP/case ($)
___ Mean (SD) = 44.7 (262.8)
Median = 0.0
Range= 0.0 – 2354.7
Overall cost due to non-EB CRP and
additional health care/year ($)
5986.0 15,662
% Hospital bill due to non-EB CRP and
additional costs/year
1.6% 4.2%
No.: number; EB: evidence-based; non-EB: non-evidence-based.
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formed per neonate was 2.9 (2.7), with a range of 1-12
tests. Among all of these CRP tests, only 34/263 (12.9%)
had an impact on clinical decision-making in terms of
continuing or stopping antibiotics. In the remaining
cases, treatment decisions were based on culture results
and/or the baby’s clinical picture, irrespective of the
value of CRP.
For the 152 children admitted to the pediatric ward, the
admission diagnoses were pneumonia (40), acute gastro-
enteritis (28), bacteremia (25), urinary tract infection
(13), acute otitis media (10), meningitis (7), soft tissue/
bone/joint infections (4), acute sinusitis (4), appendicitis
(3), tonsillitis (2), and other miscellaneous infections
(16). There was an evidence base for ordering CRP in
the ED for 40/152 (26.3%) cases. The mean (SD) number
of CRP tests performed per child during the hospital
stay was 1.7 (1.0), with a range of 1-6 tests. Of the 254
CRP tests performed during the hospital stays of these
patients, 178 (70.1%) failed to inform decision-makingand/or resulted in further unnecessary additional health
care.
Regarding the cost, the overall charges for the 517
CRP tests performed during one year was $25,316.3. In
the NICU, the overall CRP charges were $12,799.3, with
a mean (SD) of $140.7 (131.7) per neonate. Approxi-
mately $5986 (46.8%) of the total CRP charges in the
NICU was spent on tests that were unsupported by evi-
dence. When the impact of CRP testing on decision-
making was taken into consideration, the overall cost of
the 229/263 (87.1%) CRP tests that failed to inform
decision-making was estimated at $11,148.2.
Regarding ward admissions, the overall CRP charges
were $12,517 with a mean (SD) of $82.3 (48.4) per pa-
tient. Tests that were unsupported by evidence were esti-
mated to cost $8868.7 (70.9% of total ward CRP
charges). Non-EB testing resulted in the further ordering
of laboratory or radiologic tests, additional antibiotic
treatment, or the prolongation of the hospital stay for
some cases, thus leading to additional charges
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on clinical decision-making was considered by including
the CRP tests that failed to inform decision-making and/
or resulted in further unnecessary additional health care,
the expenditure on CRP testing increased to $15,567.7.
As a result, our one-year charges for routine CRP testing
in the NICU and for non-EB testing for other pediatric
infections amounted to $26,715.9.
Discussion
We investigated the impact of routine CRP ordering on
clinical decision-making in hospitalized febrile children
and neonates with suspected neonatal sepsis, the evi-
dence base for such testing, and the one-year direct
medical costs due to this practice. We found that rou-
tine CRP ordering for diagnostic purposes for these
infections failed to inform decision-making in the ma-
jority of cases while inflating hospital bills by $26,715.9.
Only 12.9% of CRP tests performed on neonates with
suspected neonatal sepsis and 29.9% of tests performed
on febrile children with suspected bacterial infections
informed decision-making. Moreover, the majority of
the ordered CRP tests did not have a solid evidence
base to support their use as diagnostic tools for the ac-
curate detection of bacterial infections. Almost half of
CRP tests ordered during the initial workup of neonatal
sepsis and about three-quarters of tests performed to
investigate or follow-up children with bacterial infec-
tions were non-EB. This practice is most likely influ-
enced by the rapidly increasing literature on the utility
of CRP levels for different infections in children and
neonates. However, recent systematic reviews have
questioned the diagnostic accuracy of CRP for serious
bacterial infections in febrile children [3-5], pneumonia
[7,8], and neonatal sepsis [4,9]. Cross-sectional, retro-
spective and case series studies, which provide a lower
level of evidence, suggest that CRP is of low diagnostic
value for the diagnosis of several other infections, such
as febrile urinary tract infections [10-13], acute febrile
gastroenteritis [14], acute appendicitis [15], acute otitis
media [16,17], community-acquired pneumonia [18],
and meningitis [19]. However, other studies suggest that
the CRP level may be of prognostic value in patients
with acute osteomyelitis or septic arthritis [20-23] and
in differentiating simple from perforated appendicitis
[24]. Two old retrospective studies reported high sensi-
tivities and negative predictive values for CRP in differ-
entiating bacterial from viral meningitis [25] and other
central nervous system infections [26]. In neonatal sep-
sis, a single CRP value was found to be a poor predictor
of sepsis [27,28], whereas serial CRP measurements
were good predictors of late-onset sepsis (LOS) in very-
low-birth-weight neonates, whether performed as single
tests or in combination with tests of the interleukin-6(IL-6) level [29]. Moreover, serial CRP values were
shown to be helpful in guiding the duration of antibiotic
therapy in two other studies [30,31]. It should be noted,
however, that all previous studies varied in their choice
of the optimal CRP cutoff value, which adds to the con-
troversy regarding the diagnostic benefit of the CRP
level for pediatric infections.
This study is the first to examine the impact of CRP
testing on clinical decision-making and to evaluate the
evidence base for the utility of this test for different
infections in children. Despite this study’s limitations,
we were able to demonstrate the small contribution
that this test makes to the diagnosis of bacterial infec-
tions in children and the impressive increase in hos-
pital bills due to its routine ordering. However, this
study suffers from several limitations. First, its retro-
spective design may introduce bias in accurately cap-
turing the treating physician’s rationale behind CRP
ordering and its effect on the management of patients
if the rationale or effects were inadequately recorded
in the patients’ medical charts. This bias was kept to a
minimum by our careful scrutiny of the written med-
ical orders and the progress notes pertaining to each
CRP test. Second, although the classification of CRP
tests as EB or non-EB was based on the highest level
of evidence available at the time of admission, most of
this evidence came from studies with a low level of
evidence, such as retrospective studies or case series,
when systematic reviews were unavailable. Third, we
found great variation in the optimal CRP cutoff level
among studies, even for the same type of infection.
However, these limitations make our calculations of the
proportion of evidence-based tests and of the extra
charges due to CRP ordering in our setting an under-
estimate of the reality. The main strength of this study
is the use of explicit criteria to classify CRP test order-
ing as EB or non-EB based on a critical review of the
literature.
Overutilization of laboratory testing is common in hos-
pital practices and has been attributed to the defensive
behavior of physicians, a lack of experience, uncertainty,
“routine” practice, a lack of awareness of the associated
costs, the use of protocols and guidelines, and other fac-
tors [32]. Inappropriate testing may increase patient anx-
iety, inflate health care costs, waste health resources, and
affect the quality of care. Unfortunately, interventions
aiming at improving appropriate laboratory ordering
have been unsuccessful [32], further adding to the com-
plexity of the problem.
Conclusion
In conclusion, routine CRP ordering for the detection of
bacterial infection in sick children and neonates needs
further scrutiny by practicing physicians. The evidence in
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infections is weak and is mostly based on studies of low
levels of evidence. The CRP test results seem to have a
small impact on decision-making and may contribute to
the unnecessary elevation of health care expenditures.
Better quality studies are needed to address the utility of
CRP testing for pediatric infections and to define a con-
sistent optimal cutoff value that can discriminate bacterial
from viral infections or other diseases.
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